Oxafine Capsule contains Oxaceprol 200 mg, a pharmacologically active compound primarily indicated for the treatment of inflammatory conditions such as osteoarthritis and rheumatoid arthritis. Oxaceprol exerts its therapeutic effects by modulating inflammatory pathways, thereby reducing joint pain, swelling, and stiffness associated with chronic musculoskeletal disorders. The mechanism of action involves the inhibition of pro-inflammatory mediators and the promotion of connective tissue repair, which contributes to improved joint function and mobility. Oxafine is administered orally and is generally well-tolerated, with a favorable safety profile compared to traditional non-steroidal anti-inflammatory drugs (NSAIDs). It is recommended for use as part of a comprehensive treatment plan, including physical therapy and lifestyle modifications, to optimize patient outcomes. Common adverse effects are mild and may include gastrointestinal discomfort, nausea, or headache; however, serious side effects are rare. Oxafine Capsule should be used with caution in patients with known hypersensitivity to Oxaceprol or related compounds. Dosage adjustments may be necessary in individuals with renal impairment. As with all medications, consultation with a healthcare professional is essential before initiating therapy to ensure appropriate use and to monitor for potential drug interactions or contraindications.